In a procedure called "allogeneic bone marrow transplant," a donor is found whose marrow matches that of the patient.
something in your mothers a#@ lmfao(:
Allogeneic means when cells are transplanted they are coming from a donor. It doesn't have to be family related, the donor can be anyone as long as it matches. Some studies have shown it can come from an actual umbilical chord.
An "allogenic" transplant is a human-to-human transplant. (A "xenogenic" transplant would be animal-to-human).
James L. Biesecker has written: 'Cellular and humoral immunity after allogeneic transplantation in the rat'
The term that refers to originating within another is allogeneic. It is a medical term that is used in transplantation biology.
12-15 lakh for an allogeneic transplant and 8-10 lakh for an autologous transplant approximately
The FDA has issued a draft Guidance recommending all allogeneic, and selected autologous, blood donations be screened for T. cruzi.
FDA guidelines require allogeneic blood donors to have a hemoglobin level or 12.5 g/dL or greater, or a hematocrit of 38% or greater. Autologous donors (self-donation) must have a hematocrit of at least 33%.
Torsten Mattsson has written: 'Oral side effects of allogeneic bone marrow transplantation' -- subject(s): Adverse effects, Bone Marrow Transplantation, Homologous Transplantation, Mouth Mucosa, Oral Manifestations
There are three types of bone marrow transplant procedure. One of the three is called an Autologous bone marrow transplant. With an Autologous bone marrow procedure, doctors take the persons own bone marrow and freeze it before chemo then reintroduce the marrow into red blood cells after chemo or radiation. The second type is Allogeneic. In an Allogeneic marrow procedure the marrow is taken from a matching marrow donor. The third type is called Umbilical cord blood transplant. With an umbilical cord blood transplant, there can be a wider variety of donor as the cells are still considered immature.
To date (April 2014) there is no cure for X-linked lymphoproliferative disease (XLP); however, research into a cure is being conducted. In one study, allogeneic hematopoietic stem cell transplantation (HSCT) showed promise of curing the disease. To read the study, visit the Related Link.